Trial NCT04777708

View at ClinicalTrials.gov 
Org. Study IDs: 21-000276
Secondary IDs: 21-000276 NCI-2021-00994

Last trial update was posted on 2023-03-24

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular

Other Conditions

Advanced Hepatocellular Carcinoma BCLC Stage B Hepatocellular Carcinoma BCLC Stage C Hepatocellular Carcinoma Refractory Hepatocellular Carcinoma

Stopping Reasons

Withdrawn by sponsor

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID